Computer modeling of diabetes and its complications -: A report on the Fourth Mount Hood Challenge Meeting

被引:170
作者
Palmer, Andrew J.
Roze, Stephane
Valentine, William J.
McEwan, Philip
Gillett, Michael
Holmes, Michael
Clarke, Philip
Stevens, Richard
Gray, Alastair M.
Coleman, Ruth
Sorensen, Stephen
Mueller, Elvira
Walzer, Stefan
Eddy, David M.
Kahn, Richard
Bagust, Adrian
Brown, Jonathan
Brennan, Alan
Chan, Wiley
Russell, Alan
Hoerger, Thomas
Hicks, Katherine
Casciano, Roman
Bergemann, Rito
机构
[1] CORE, Basel, Switzerland
[2] Cardiff Univ, Cardiff, Wales
[3] Univ Sheffield, CIMA, Sheffield, S Yorkshire, England
[4] Univ Oxford, UKPDS, Oxford, England
[5] Ctr Dis Control & Prevent, Atlanta, GA USA
[6] Analyt Int, EAGLE Model, Lorrach, Germany
[7] Kaiser Permanente, San Francisco, CA USA
[8] ADA, Alexandria, VA USA
[9] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[10] Kaiser Permanente Ctr Hlth Res, Portland, OR USA
关键词
D O I
10.2337/dc07-9919
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Computer simulation models are mathematical equations combined in a structured framework to represent some real or hypothetical system. One of their uses is to allow the projection of short-term data from clinical trials to evaluate clinical outcomes and costs over a long-term period. This technology is becoming increasingly important to assist decision making in modern medicine in situations where there is a paucity of long-term clinical trial data, as recently acknowledged in the American Diabetes Association Consensus Panel Guidelines for Computer Modeling of Diabetes and its Complications. The Mount Hood Challenge Meetings provide a forum for computer modelers of diabetes to discuss and compare models and identify key areas of future development to advance the field. The Fourth Mount Hood Challenge in 2004 was the first meeting of its kind to ask modelers to perform simulations of outcomes for patients in published clinical trials, allowing comparison against "real life" data. Eight modeling groups participated in the challenge. Each group was given three of the following challenges: to simulate a trial of type 2 diabetes (CARDS fCollaborative Atorvastatin Diabetes Study]); to simulate a trial of type I diabetes (DCCT [Diabetes Control and Complications Trial]); and to calculate outcomes for a hypothetical, precisely specified patient (cross-model validation). The results of the models varied from each other and for methodological reasons, in some cases, from the published trial data in important ways. This approach of performing systematic comparisons and validation exercises has enabled the identification of key differences among the models, as well as their possible causes and directions for improvement in the future.
引用
收藏
页码:1638 / 1646
页数:9
相关论文
共 41 条
[1]   Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) [J].
Adler, AI ;
Stevens, RJ ;
Manley, SE ;
Bilous, RW ;
Cull, CA ;
Holman, RR .
KIDNEY INTERNATIONAL, 2003, 63 (01) :225-232
[2]  
*AM DIAB ASS, 1995, DIABETES CARE, V18, P361
[3]  
[Anonymous], 1996, DIABETES, V45, P1289
[5]   Effect of screening and adjuvant therapy on mortality from breast cancer [J].
Berry, DA ;
Cronin, KA ;
Plevritis, SK ;
Fryback, DG ;
Clarke, L ;
Zelen, M ;
Mandelblatt, JS ;
Yakovlev, AY ;
Habbema, JDF ;
Feuer, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1784-1792
[6]   MODEL UNCERTAINTY, DATA MINING AND STATISTICAL-INFERENCE [J].
CHATFIELD, C .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 1995, 158 :419-466
[7]   A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) [J].
Clarke, PM ;
Gray, AM ;
Briggs, A ;
Farmer, AJ ;
Fenn, P ;
Stevens, RJ ;
Matthews, DR ;
Stratton, IM ;
Holman, RR .
DIABETOLOGIA, 2004, 47 (10) :1747-1759
[8]  
Coleman RL, 2005, DIABETES, V54, pA172
[9]   Design of the collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes [J].
Colhoun, HM ;
Thomason, MJ ;
Mackness, MI ;
Maton, SM ;
Betteridge, DJ ;
Durrington, PN ;
Hitman, GA ;
Neil, HAW ;
Fuller, JH .
DIABETIC MEDICINE, 2002, 19 (03) :201-211
[10]   Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].
Colhoun, HM ;
Betteridge, DJ ;
Durrington, PN ;
Hitman, GA ;
Neil, HAW ;
Livingstone, SJ ;
Thomason, MJ ;
Mackness, MI ;
Charlton-Menys, V ;
Fuller, JH .
LANCET, 2004, 364 (9435) :685-696